SynthesisMicrobial biotechnology2025
Acinetobacter baumannii as a Model for the Study and Application of Gram-Negative Outer Membrane Vesicles: A Systematic Review.
Synthesis in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Acinetobacter baumannii as a Model for the Study and Application of Gram-Negative Outer Membrane Vesicles: A Systematic Review.Microbial biotechnology · 2025Pooled it
- Bacterial Extracellular Vesicles in Biomedical Research and Clinical Translation.Microbial biotechnology · 2026Review
- Bacterial outer membrane vesicles as intrinsically immunogenic and highly modifiable nanocarriers for precision tumor therapy.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Outer membrane vesicles (OMVs) are extracellular nanostructures released from Gram-negative bacteria. Acinetobacter baumannii OMVs (AbOMVs) have been extensively studied and can thus be used as a model for understanding multiple aspects of OMV biology. In this systematic review, we comprehensively assess the relevant literature covering AbOMVs and present these studies in the context of OMV biology in general. An overview of current knowledge regarding AbOMV biogenesis is presented, focusing on the cellular, intrinsic and extracellular factors that induce AbOMV production. In addition, the components that form the AbOMVs, with an emphasis on protein content, are described. Different methodologies that have been used to isolate and purify the AbOMVs for different studies and applications are discussed. In addition, we provide a synthesis of the different roles played by AbOMVs in bacterial pathobiology, including the delivery of virulence factors, activation of immune response, gene transfer and antibiotic resistance. Finally, we detail the biotechnological applications that have employed AbOMVs, focusing on the development of AbOMV-based vaccines. Altogether, this systematic review offers a perspective of current knowledge of AbOMV and serves as a case study of Gram-negative OMVs in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.